Ascend Wellness Holdings Inc

OTCQX:AAWH USA Drug Manufacturers - Specialty & Generic
Market Cap
$70.79 Million
Market Cap Rank
#21353 Global
#7663 in USA
Share Price
$0.35
Change (1 day)
+1.16%
52-Week Range
$0.34 - $0.37
All Time High
$11.25
About

Ascend Wellness Holdings, Inc. engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flowers, pre-rolls, concentrates, vapes, edibles, tablets, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Effin', Miss Grass, Lowell Smokes, Flower by Edie Parker, 1906, AiroPro,… Read more

Ascend Wellness Holdings Inc (AAWH) - Net Assets

Latest net assets as of September 2025: $2.58 Million USD

Based on the latest financial reports, Ascend Wellness Holdings Inc (AAWH) has net assets worth $2.58 Million USD as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($900.36 Million) and total liabilities ($897.78 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $2.58 Million
% of Total Assets 0.29%
Annual Growth Rate 108.68%
5-Year Change N/A
10-Year Change N/A
Growth Volatility 1985.23

Ascend Wellness Holdings Inc - Net Assets Trend (2020–2024)

This chart illustrates how Ascend Wellness Holdings Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Ascend Wellness Holdings Inc (2020–2024)

The table below shows the annual net assets of Ascend Wellness Holdings Inc from 2020 to 2024.

Year Net Assets Change
2024-12-31 $71.80 Million -49.74%
2023-12-31 $142.87 Million -12.57%
2022-12-31 $163.41 Million -7.40%
2021-12-31 $176.48 Million +4561.30%
2020-12-31 $3.79 Million --

Equity Component Analysis

This analysis shows how different components contribute to Ascend Wellness Holdings Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 33676400000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Other Components $471.33 Million 664.06%
Total Equity $70.98 Million 100.00%

Ascend Wellness Holdings Inc Competitors by Market Cap

The table below lists competitors of Ascend Wellness Holdings Inc ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Ascend Wellness Holdings Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 142,872,000 to 70,978,000, a change of -71,894,000 (-50.3%).
  • Net loss of 84,994,000 reduced equity.
  • Share repurchases of 2,751,000 reduced equity.
  • Other factors increased equity by 15,851,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income $-84.99 Million -119.75%
Share Repurchases $2.75 Million -3.88%
Other Changes $15.85 Million +22.33%
Total Change $- -50.32%

Book Value vs Market Value Analysis

This analysis compares Ascend Wellness Holdings Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.01x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 15.78x to 1.01x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2020-12-31 $0.02 $0.35 x
2021-12-31 $1.03 $0.35 x
2022-12-31 $0.87 $0.35 x
2023-12-31 $0.69 $0.35 x
2024-12-31 $0.35 $0.35 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Ascend Wellness Holdings Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -119.75%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -15.13%
  • • Asset Turnover: 0.62x
  • • Equity Multiplier: 12.69x
  • Recent ROE (-119.75%) is above the historical average (-188.88%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2020 -671.92% -17.70% 0.34x 112.98x $-25.82 Million
2021 -69.50% -36.90% 0.46x 4.10x $-140.30 Million
2022 -49.51% -19.93% 0.47x 5.34x $-97.24 Million
2023 -33.75% -9.30% 0.56x 6.44x $-62.50 Million
2024 -119.75% -15.13% 0.62x 12.69x $-92.09 Million

Industry Comparison

This section compares Ascend Wellness Holdings Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $593,514,903
  • Average return on equity (ROE) among peers: -496.66%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Ascend Wellness Holdings Inc (AAWH) $2.58 Million -671.92% 348.25x $48.90 Million
AB Science S.A (ABSCF) $10.73 Million -252.65% 3.71x $39.89 Million
Alterola Biotech Inc (ABTI) $4.85K -2005.32% 0.49x $603.58K
Aurora Cannabis Inc (ACB) $2.04 Billion -34.08% 0.34x $199.15 Million
Acreage Holdings Inc (ACRDF) $204.27 Million -30.85% 1.41x $13.48K
Acura Pharmaceuticals Inc (ACUR) $7.90 Million -63.15% 1.15x $13.20K
Agra Ventures Ltd. (AGFAF) $1.51 Million -44.22% 0.06x $298.23K
Allergy Therapeutics plc (AGYTF) $2.07 Million -2084.75% 31.32x $25.30 Million
Aida Pharmaceuticals Inc (AIDA) $6.67 Million 24.51% 2.78x $1.80
Adcock Ingram Holdings Limited (AIHLF) $3.07 Billion 20.55% 0.55x $85.61 Million